4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-23-093069
VP, Research & Development acquired 35,115 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hayon Yael VP, Research & Development | 2023-08-15 | Grant or award | +35,115 | 35,115 | I | ||
| Derivatives | |||||||
| Hayon Yael VP, Research & Development | 2023-08-15 | Grant or award · Stock Options (Right to Buy) | +35,115 | 35,115 | D | ||
Loading xslF345X05/tm2324046-2_4seq1.xml…